New drugs for treatment of attention-deficit/hyperactivity disorder

By Chung Bowen   Suzuki Alejandra R   McGough James J  

Expert Opinion on Emerging Drugs, Vol. 7, Iss. 2, 2002-10 ,pp. : 269-276

Informa Healthcare

Access to resources Recommend Favorite

New drugs for the treatment of attention-deficit/hyperactivity disorder

By Pataki Caroly S   Feinberg David T   McGough James J  

Expert Opinion on Emerging Drugs, Vol. 9, Iss. 2, 2004-11 ,pp. : 293-302

Informa Healthcare

Access to resources Recommend Favorite

Do adrenergically active drugs have a role in the first-line treatment of attention-deficit/hyperactivity disorder?

By Hazell Philip  

Expert Opinion on Pharmacotherapy, Vol. 6, Iss. 12, 2005-10 ,pp. : 1989-1998

Informa Healthcare

Access to resources Recommend Favorite

Postnatal Brain Development and Psychotropic Drugs. Effects on Animals and Animal Models of Depression and Attention-Deficit/Hyperactivity Disorder

By  

Current Pharmaceutical Design, Vol. 16, Iss. 22, 2010-07 ,pp. : 2474-2483

Bentham Science Publishers

Access to resources Recommend Favorite

Attention-Deficit/Hyperactivity Disorder Subtypes in Adolescents with Comorbid Substance-Use Disorder

By Tamm Leanne   Adinoff Bryon   Nakonezny Paul A.   Winhusen Theresa   Riggs Paula  

The American Journal of Drug and Alcohol Abuse, Vol. 38, Iss. 1, 2012-01 ,pp. : 93-100

Informa Healthcare

Access to resources Recommend Favorite